z-logo
Premium
增加心血管药物依从性:一个医学研究委员会综合mhealth干预混合方法可行性研究,以告知全球实践
Author(s) -
Khonsari Sahar,
Chandler Colin,
Parker Richard,
Holloway Aisha
Publication year - 2020
Publication title -
journal of advanced nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 155
eISSN - 1365-2648
pISSN - 0309-2402
DOI - 10.1111/jan.14465
Subject(s) - mhealth , medicine , randomized controlled trial , intervention (counseling) , medication adherence , coronary heart disease , clinical trial , physical therapy , quality of life (healthcare) , focus group , family medicine , nursing , psychological intervention , marketing , business
Aims To evaluate a mHealth intervention to increase medication adherence among Iranian coronary heart disease patients. Design Quantitative‐dominant mixed‐methods study. Data Source Iranian coronary heart disease patients’ responses and most recent clinical documents as well as responses from Iranian cardiac nurses who participated in this study. Methods The study was conducted between September 2015–April 2016 drawing on the Medical Research Council's Framework. Phase one comprised of a patients’ survey and focus groups with cardiac nurses. The automated short message service reminder was piloted in phase two. We recruited 78 patients and randomized to receive either 12‐week daily reminders or usual care. The primary outcome was the effect on medication adherence; secondary outcomes were self‐efficacy, ejection fraction, functional capacity, readmission rate and quality of life. Results Feasibility was evidenced by high ownership of mobile phones and high interest in receiving reminders. Participants in the intervention group showed significantly higher medication adherence compared with the control group. Conclusion The mHealth intervention was well accepted and feasible with early evidence of effectiveness that needs to be confirmed in a fully powered future randomized clinical trial.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here